Skip to content

D&A at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$563M-0.7%
Boston Scientific logo
Boston ScientificBSX
$351M+8.0%
Medtronic logo
MedtronicMDT
$716M-14.8%
Solventum logo
SolventumSOLV
$135M+4.7%
Baxter International logo
Baxter InternationalBAX
$237M-4.0%
Edwards Lifesciences logo
Edwards LifesciencesEW
$40.9M+11.7%

Segments

By segment

See full
Americas$21.68M-1.8%
EMEA$20.31M+122%
Corporate$7.08M+51.1%
Asia$4.68M+71.9%

Other financials

Income statement

See full
Revenue$548.3M+32.3%
Gross profit$307.4M+20.4%
Operating income$20.2M-73.4%
Net income-$8.2M-109%
EPS (diluted)-$0.18-109%

Balance sheet

See full
Cash & equivalents$329.6M+16.8%
Total debt$2.8B+38.6%
Total equity$3.1B-24.7%
Total assets$6.8B-5.3%

Cash flow

See full
Operating cash flow$46.7M+68.3%
CapEx$18.8M-22.1%
Free cash flow$27.9M+676%

Valuation

See full
Market cap$5.62B-14.4%
Enterprise value$8.07B-2.0%
P/S2.6×-1.2×

Profitability

See full
Gross margin38.2%-3.0pp
Operating margin3%-11.8pp
Net margin-47.4%-56.2pp
FCF margin7.9%

Returns & leverage

See full
Return on equity-28.1%-31.6pp
Debt / equity0.9×+0.4×
Current ratio2.6×+0.3×

Where this comes from

Reported directly by Teleflex in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Teleflex’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Teleflex's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Teleflex's D&A?
Teleflex (TFX) reported D&A of $19.85M in Q1 2026.
How has Teleflex's D&A changed year-over-year?
Teleflex's D&A increased by 52.3% year-over-year, from $13.04M to $19.85M.
What is the long-term trend for Teleflex's D&A?
Over 4 years (2021 to 2025), Teleflex's D&A has grown at a -4.9% compound annual growth rate (CAGR), from $71.76M to $58.74M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.